Sickle cell paths converge on hydroxyurea

Nat Med. 1995 Apr;1(4):307-8. doi: 10.1038/nm0495-307.
No abstract available

MeSH terms

  • Adult
  • Anemia, Sickle Cell / drug therapy*
  • Anemia, Sickle Cell / etiology
  • Antisickling Agents / therapeutic use*
  • Azacitidine / therapeutic use
  • Child
  • Fetal Hemoglobin / physiology
  • Hemoglobin, Sickle / genetics
  • Hemoglobin, Sickle / metabolism*
  • Humans
  • Hydroxyurea / therapeutic use*
  • Mutation

Substances

  • Antisickling Agents
  • Hemoglobin, Sickle
  • Fetal Hemoglobin
  • Azacitidine
  • Hydroxyurea